PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis.
Saved in:
| Title: | PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis. |
|---|---|
| Authors: | Ghate K; Department of Oncology, Queen's University, Kingston, Ontario, Canada., Amir E; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Kuksis M; Department of Medicine, Queen's University, Kingston, Ontario, Canada., Hernandez-Barajas D; Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico., Rodriguez-Romo L; Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada., Booth CM; Department of Oncology, Queen's University, Kingston, Ontario, Canada., Vera-Badillo FE; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: fverabadillo@ctg.queensu.ca. |
| Source: | Cancer treatment reviews [Cancer Treat Rev] 2019 Jun; Vol. 76, pp. 51-56. Date of Electronic Publication: 2019 May 16. |
| Publication Type: | Journal Article; Meta-Analysis; Systematic Review |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31125908 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ghate+K%22">Ghate K</searchLink>; Department of Oncology, Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Amir+E%22">Amir E</searchLink>; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kuksis+M%22">Kuksis M</searchLink>; Department of Medicine, Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hernandez-Barajas+D%22">Hernandez-Barajas D</searchLink>; Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Romo+L%22">Rodriguez-Romo L</searchLink>; Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Booth+CM%22">Booth CM</searchLink>; Department of Oncology, Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Vera-Badillo+FE%22">Vera-Badillo FE</searchLink>; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: fverabadillo@ctg.queensu.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227502030%22">Cancer treatment reviews</searchLink> [Cancer Treat Rev] 2019 Jun; Vol. 76, pp. 51-56. <i>Date of Electronic Publication: </i>2019 May 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Meta-Analysis; Systematic Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7502030 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1967 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057372%22">03057372 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Treat Rev <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31125908 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ctrv.2019.05.002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 51 Titles: – TitleFull: PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ghate K – PersonEntity: Name: NameFull: Amir E – PersonEntity: Name: NameFull: Kuksis M – PersonEntity: Name: NameFull: Hernandez-Barajas D – PersonEntity: Name: NameFull: Rodriguez-Romo L – PersonEntity: Name: NameFull: Booth CM – PersonEntity: Name: NameFull: Vera-Badillo FE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2019 Jun Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1532-1967 Numbering: – Type: volume Value: 76 Titles: – TitleFull: Cancer treatment reviews Type: main |
| ResultId | 1 |
